Literature DB >> 25555276

Improved renal function in a patient with hypertrophic obstructive cardiomyopathy after multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation.

Yuichiro Maekawa1, Masahiro Jinzaki2, Hikaru Tsuruta3, Keitaro Akita3, Yoshitake Yamada2, Takashi Kawakami3, Kentaro Hayashida3, Shinsuke Yuasa3, Mitsushige Murata3, Keiichi Fukuda3.   

Abstract

Entities:  

Keywords:  Chronic kidney disease; Hypertrophic obstructive cardiomyopathy; Multidetector computed tomography; Percutaneous transluminal septal myocardial ablation

Mesh：

Year:  2014        PMID： 25555276     DOI： 10.1016/j.ijcard.2014.12.078

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  6 in total

1.  Morphine but not fentanyl and methadone affects mitochondrial membrane potential by inducing nitric oxide release in glioma cells.

Authors:  D Mastronicola; E Arcuri; M Arese; A Bacchi; S Mercadante; P Cardelli; G Citro; P Sarti
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

2.  Renal function after repeat catheter ablation for long-standing persistent atrial fibrillation : Low CHA2DS2-VASc score and sinus rhythm predict improved renal function.

Authors:  Q Wang; X-D Zhang; X Liu; Y-Q Yang
Journal:  Herz       Date:  2016-01-25       Impact factor: 1.443

Review 3.  Obstructive Form of Hypertrophic Cardiomyopathy-Left Ventricular Outflow Tract Gradient: Novel Methods of Provocation, Monitoring of Biomarkers, and Recent Advances in the Treatment.

Authors:  Pawel Petkow Dimitrow; Renata Rajtar-Salwa
Journal:  Biomed Res Int       Date:  2016-05-10       Impact factor: 3.411

4.  Risk of glomerular filtration rate decline in patients with hypertrophic cardiomyopathy and obstructive sleep apnoea.

Authors:  Shao-Yun Wang; Jing Luo; Yi-Fei Dong; Xu-Yang Liu; Ying-Li Fan; Ming Deng; Da-Wei Chen; Ping Li; Xiao-Shu Cheng
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

5.  Risk of end-stage renal disease in patients with hypertrophic cardiomyopathy: A nationwide population-based cohort study.

Authors:  Heesun Lee; Kyungdo Han; Jun-Bean Park; In-Chang Hwang; Yeonyee E Yoon; Hyo Eun Park; Su-Yeon Choi; Yong-Jin Kim; Goo-Yeong Cho; Hyung-Kwan Kim; Steve R Ommen
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

6.  Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy.

Authors:  Shengwei Wang; Hao Cui; Keshan Ji; Changpeng Song; Changwei Ren; Hongchang Guo; Changsheng Zhu; Shuiyun Wang; Yongqiang Lai
Journal:  Cardiovasc Diabetol       Date:  2020-05-13       Impact factor: 9.951
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.